Immunosuppressive tumor mechanisms include checkpoint inhibitor mAb's targeting inhibitory T-cell checkpoints of PD-1 and CTLA-4, and other targeted antibodies (e.g., against CD25) that deplete inhibitory regulatory Treg cells (16). Here, CTLA4 is linked to neoplasm.